Clinical Studies – Beta Glucan for Medical Professionals

  CLINICAL STUDIES FOR MEDICAL PROFESSIONALS Complement activation by mAbs can cause direct tumor cell lysis or enhance antibody-dependent cell-mediated cytotoxicity. However, tumor cells are protected from complement-mediated injury by membrane-bound complement regulatory proteins (mCRP) that are often expressed at elevated levels on tumor cells. Recent studies indicate that blocking or over-whelming the function of […]